Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair

项目总结 在这项提案中，我们的目标是设计一种生物材料支架，通过改进 我们发明的水凝胶生物材料的新亚类称为微孔退火颗粒凝胶或MAP凝胶。地图 凝胶由使用微流控生成并原位组装成的微观球形构建块组成 形成稳定的地图脚手架。MAP支架已经被证明可以通过一种 减少伤口炎症，促进细胞/组织整合。我们专注于 材料改进以应对糖尿病创面材料治疗的三个已知困难：异常 免疫活性高，降解微环境增加，新组织生成减少。具体来说，我们 我已经确定了三个我们可以独立调节以进行科学优化的地图属性：孔隙几何 (已知的免疫调节参数)，可降解性(过早的材料降解会导致多孔丧失 几何构型)，以及非均相肝素“微岛”(我们开发的一种新的材料策略，以改善内部 支架血管生成)。我们假设，单独调查和优化每一处房产将加快 糖尿病伤口闭合，最后，优化的性能可以协同结合。 我们将使用以下表征工作流程评估和优化每种材料特性：体外特性 量化(属性相关)、体外细胞反应(存活、增殖和迁移)、体内免疫 反应(FACS分析)、体内材料降解(组织学分析)和体内组织愈合/再生 (免疫组织学分析)。我们的研究集中在糖尿病伤口环境中，通过使用真皮细胞系 体外和糖尿病小鼠(db/db)夹板伤口愈合模型。我们方法的每个目标都孤立了一个人 材料属性，以简化调查。例如，使用单个水凝胶来研究孔几何形状的影响。 配方和水凝胶配方影响使用单一孔道几何形状(采用恒定配方和孔道几何形状 来自我们成功的非糖尿病研究)。如果成功，这个项目将提供对组织反应的更好的理解 一种新的生物材料，并产生一种廉价有效的支架治疗方案，用于加速糖尿病 伤口闭合。

PROJECT SUMMARY In this proposal, we aim to engineer a biomaterial scaffold to accelerate diabetic wound closure by improving upon a new sub-class of hydrogel biomaterials we have invented called Microporous Annealed Particle gel or MAP gel. MAP gels are composed of microscopic spherical building blocks made using microfluidic generation and assembled in situ to form a stable MAP scaffold. MAP scaffolds have been shown to improve tissue healing in both skin and brain through a porosity-dependent reduction in wound inflammation and promotion of cell/tissue integration. We are focusing on material improvements to counter three known difficulties for material-based treatment of diabetic wounds: abnormally high immune activation, increased degradative microenvironment, and diminished new tissue generation. Specifically, we have identified three MAP properties that we can independently modulate for scientific optimization: pore geometry (known immunomodulatory parameter), degradability (premature material degradation results in loss of porous geometry), and heterogeneous heparin “micro-islands” (a novel material strategy we have developed to improve intra- scaffold angiogenesis). We hypothesize that investigating and optimizing each property individually will accelerate diabetic wound closure and, finally, that the optimized properties can be combined synergistically. We will evaluate and optimize each material property using the following characterization workflow: in vitro property quantification (property-dependent), in vitro cell response (survival, proliferation, and migration), in vivo immune response (analysis by FACS), in vivo material degradation (analysis by histology), and in vivo tissue healing/regeneration (analysis by immunohistology). Our studies focus on the diabetic wound environment through use of dermal cell lines in vitro and a diabetic mouse (db/db) splinted wound healing model. Each Aim of our approach isolates an individual material property to simplify the investigation. For example, pore geometry impact is investigated using a single hydrogel formulation and hydrogel formulation impact uses a single pore geometry (constant formulation and pore geometry taken from our successful non-diabetic studies). If successful, this project will provide a better understanding of tissue response to a new class of biomaterial and produce an inexpensive and effective scaffold treatment option for accelerating diabetic wound closure.